EMPROVE® bio Portfolio
Raw material qualification is a key factor in assuring the quality and safety of biopharmaceuticals. Even still, performing tests and compiling required documentation on your own is costly and time-consuming. Enter EMPROVE® bio raw materials – your solution for getting products to market faster. EMPROVE® bio raw materials for use in biopharmaceutical production offer specifications adapted for use in upstream or downstream pr…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Raw material qualification is a key factor in assuring the quality and safety of biopharmaceuticals. Even still, performing tests and compiling required documentation on your own is costly and time-consuming. Enter EMPROVE® bio raw materials – your solution for getting products to market faster.
EMPROVE® bio raw materials for use in biopharmaceutical production offer specifications adapted for use in upstream or downstream process steps. These dossiers contain comprehensive data on the manufacturing processes, testing procedures and purity. Select EMPROVE® bio products also comply with ACS standards.
With EMPROVE® bio, you benefit from Merck Millipore’s known expertise and reputation for uncompromising reliability and safety. As a result, you can considerably accelerate your qualification, helping you to reduce your workload and costs.
EMPROVE® bio Portfolio Features:
- Analytical Dossier
- CDA necessary
- Charged
- In line with CTD format - Basic Dossier
- Available online
- Free of charge - Specification adapted to biopharmeceutical production process
- Endotoxins: tested (partly)
- Microbiology: tested (partly)
- Proteases: tested (partly)
- ACS reagent standard: tested (partly)
- In line with CTD format
